International Development Grant
Global Fund to Fight AIDS Tuberculosis and Malaria - Institutional Support 2020 to 2022
Project Number: CA-3-P005247001
Status: Closed
Country/Region: Unknown
Regional Focus:
Maximum Contribution: $930,400,000.00
Start Date: December 16, 2020
End Date: December 31, 2022
Duration: 2.0 years
Project Description
This grant represents Canada’s long-term institutional support to the Global fund to fight AIDS tuberculosis and malaria. The Global Fund to Fight AIDS Tuberculosis and Malaria uses these funds along with other donors’ funding to achieve its mandate. The Global Fund to Fight AIDS Tuberculosis and Malaria is a unique public-private partnership and international financing institution dedicated to attracting and disbursing additional resources to prevent and treat AIDS tuberculosis and malaria. It is a partnership between governments civil society the private sector and affected communities which represents an innovative approach to international health financing. The Global Fund’s model is based on the concepts of country ownership and performance-based funding. This means that organizations in developing countries implement their own programs based on their own priorities and must be able to show the results achieved. Since its creation in 2002 the Global Fund has become the main global financier of programs to fight AIDS tuberculosis and malaria with approved funding in more than 100 countries. This grant contributes towards meeting the Sustainable Development Goal target of eliminating HIV tuberculosis and malaria as epidemics by 2030 by supporting countries to scale up treatment and prevention services. This grant also contributes to improving the health and rights of women and children (including adolescents) and focuses international assistance efforts on helping the poorest and most vulnerable.
Expected Results
The expected outcomes as stated by the “Global Fund Strategy 2017-2022” include: (1) supported 90% of persons living with HIV (PLHIV) to know their status 90% PLHIV know their status and received treatment and 90% of people on treatment suppressed viral loads; (2) enabled a 20% and 35% decline in TB incidence rate and TB deaths respectively compared to 2015; and (3) reduced at least a 40% in malaria mortality rates and malaria case incidence compared to 2015.
Progress & Results Achieved
Results achieved as of November 2022 include: (1) supported 85% of people living with Human Immunodeficiency Virus (HIV) to know their status; 88% of people who know their HIV status received treatment and 92% of people on HIV treatment suppressed viral loads; (2) enabled a 22% decline in the tuberculosis (TB) incidence rate and a 8% decline in the TB death rate; and (3) reduced by 10% in malaria deaths and 17% reduction in malaria case incidence. Also in 2021 alone Global Fund programs: (1) facilitated the treatment of 148 million cases of malaria; (2) distributed 133.2 million mosquito nets to protect families from malaria transmission; (3) enabled 23.3 million people to receive lifesaving antiretroviral therapy for HIV; (4) reached 4.4 million adolescent girls and young women with HIV prevention programs in Sub-Saharan Africa; (5) enabled 670 000 mothers living with HIV to receive medicine to keep them alive and prevent transmitting HIV to their babies; (6) treated 5.3 million people for tuberculosis; and (7) enabled 395 000 people in contact with tuberculosis patients to receive preventative therapy.
Key Information
Executing Agency:
Global Fund to Fight AIDS Tuberculosis & Malaria
Reporting Organization:
Global Affairs Canada
Program:
YFMInternaAssistPartnershp&Programing Br
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Core contributions to multilateral institutions
Collaboration: Multilateral
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Institutional Support